159 related articles for article (PubMed ID: 22300412)
1. Pityriasis amiantacea: a distinctive presentation of psoriasis associated with tumour necrosis factor-α inhibitor therapy.
Ettler J; Wetter DA; Pittelkow MR
Clin Exp Dermatol; 2012 Aug; 37(6):639-41. PubMed ID: 22300412
[TBL] [Abstract][Full Text] [Related]
2. Pityriasis amiantacea: a case report.
Ayanlowo OO; Olowoyo OO; Akinkugbe AO; Adelekan FA; Ahamneze NC
Niger Postgrad Med J; 2014 Jun; 21(2):196-8. PubMed ID: 25167599
[TBL] [Abstract][Full Text] [Related]
3. Anti-TNF-alpha induced psoriasiform eruptions with severe scalp involvement and alopecia: report of five cases and review of the literature.
Osório F; Magro F; Lisboa C; Lopes S; Macedo G; Bettencourt H; Azevedo F; Magina S
Dermatology; 2012; 225(2):163-7. PubMed ID: 23052429
[TBL] [Abstract][Full Text] [Related]
4. [Pityriasis amiantacea and folliculitis decalvans : An unusual manifestation associated with antitumor necrosis factor-α therapy].
Zamperetti M; Zelger B; Höpfl R
Hautarzt; 2017 Dec; 68(12):1007-1010. PubMed ID: 29038892
[TBL] [Abstract][Full Text] [Related]
5. TNF-α inhibitor (adalimumab) induced psoriasis: a case report.
Al-Mutairi A; Elkashlan M; Al-Fayed HM; Swayed M
Australas J Dermatol; 2012 May; 53(2):157. PubMed ID: 22571571
[No Abstract] [Full Text] [Related]
6. Psoriasis associated with anti-tumour necrosis factor therapy in inflammatory bowel disease: a new series and a review of 120 cases from the literature.
Cullen G; Kroshinsky D; Cheifetz AS; Korzenik JR
Aliment Pharmacol Ther; 2011 Dec; 34(11-12):1318-27. PubMed ID: 21957906
[TBL] [Abstract][Full Text] [Related]
7. Histopathologic spectrum of psoriasiform skin reactions associated with tumor necrosis factor-α inhibitor therapy. A study of 16 biopsies.
Laga AC; Vleugels RA; Qureshi AA; Velazquez EF
Am J Dermatopathol; 2010 Aug; 32(6):568-73. PubMed ID: 20520526
[TBL] [Abstract][Full Text] [Related]
8. Anti-tumor necrosis factor alpha-induced psoriasiform eruptions: three further cases and current overview.
Pirard D; Arco D; Debrouckere V; Heenen M
Dermatology; 2006; 213(3):182-6. PubMed ID: 17033165
[TBL] [Abstract][Full Text] [Related]
9. Pattern and Severity of Psoriasiform Eruptions in Patients with Inflammatory Bowel Diseases, Arthritis or Skin Inflammatory Disorders Treated with TNF-alpha Inhibitors.
Darrigade AS; Milpied B; Truchetet ME; Schaeverbeke T; Laharie D; Zerbib F; Beylot-Barry M; Jouary T; Taïeb A; Ezzedine K; Seneschal J
Acta Derm Venereol; 2017 Jun; 97(6):731-734. PubMed ID: 28218339
[TBL] [Abstract][Full Text] [Related]
10. Psoriatic alopecia/alopecia areata-like reactions secondary to anti-tumor necrosis factor-α therapy: a novel cause of noncicatricial alopecia.
Doyle LA; Sperling LC; Baksh S; Lackey J; Thomas B; Vleugels RA; Qureshi AA; Velazquez EF
Am J Dermatopathol; 2011 Apr; 33(2):161-6. PubMed ID: 21317611
[TBL] [Abstract][Full Text] [Related]
11. Cutaneous manifestations in inflammatory bowel diseases: eight cases of psoriasis induced by anti-tumor-necrosis-factor antibody therapy.
Passarini B; Infusino SD; Barbieri E; Varotti E; Gionchetti P; Rizzello F; Morselli C; Tambasco R; Campieri M
Dermatology; 2007; 215(4):295-300. PubMed ID: 17911986
[TBL] [Abstract][Full Text] [Related]
12. Pityriasis amiantacea.
Moon CM; Schissel DJ
Cutis; 1999 Mar; 63(3):169-70. PubMed ID: 10190070
[TBL] [Abstract][Full Text] [Related]
13. Psoriasiform and pustular eruption induced by infliximab.
Takahashi H; Hashimoto Y; Ishida-Yamamoto A; Ashida T; Kohgo Y; Iizuka H
J Dermatol; 2007 Jul; 34(7):468-72. PubMed ID: 17584325
[TBL] [Abstract][Full Text] [Related]
14. Adalimumab-induced psoriatic alopecia/alopecia areata-like reaction in a patient with Crohn's disease.
Toda-Brito H; Lopes L; Soares-Almeida L; Filipe P
Dermatol Online J; 2015 Nov; 21(11):. PubMed ID: 26632930
[TBL] [Abstract][Full Text] [Related]
15. Adalimumab-induced psoriasis of the scalp with diffuse alopecia: a severe potentially irreversible cutaneous side effect of TNF-alpha blockers.
El Shabrawi-Caelen L; La Placa M; Vincenzi C; Haidn T; Muellegger R; Tosti A
Inflamm Bowel Dis; 2010 Feb; 16(2):182-3. PubMed ID: 19462433
[No Abstract] [Full Text] [Related]
16. Psoriasis induced by tumor necrosis factor-alpha antagonist therapy: a case series.
Cohen JD; Bournerias I; Buffard V; Paufler A; Chevalier X; Bagot M; Claudepierre P
J Rheumatol; 2007 Feb; 34(2):380-5. PubMed ID: 17013997
[TBL] [Abstract][Full Text] [Related]
17. Analysis of anti-tumour necrosis factor-induced skin lesions reveals strong T helper 1 activation with some distinct immunological characteristics.
Stoffel E; Maier H; Riedl E; Brüggen MC; Reininger B; Schaschinger M; Bangert C; Guenova E; Stingl G; Brunner PM
Br J Dermatol; 2018 May; 178(5):1151-1162. PubMed ID: 29143979
[TBL] [Abstract][Full Text] [Related]
18. Psoriasiform eruptions during anti TNF-alpha treatment: psoriasis or not?
Seneschal J; Lepreux S; Milpied B; Schaeverbeke T; Taïeb A
Arch Dermatol; 2007 Dec; 143(12):1593-5; author reply 1595. PubMed ID: 18087021
[No Abstract] [Full Text] [Related]
19. Psoriasis and pustular dermatitis triggered by TNF-{alpha} inhibitors in patients with rheumatologic conditions.
de Gannes GC; Ghoreishi M; Pope J; Russell A; Bell D; Adams S; Shojania K; Martinka M; Dutz JP
Arch Dermatol; 2007 Feb; 143(2):223-31. PubMed ID: 17310002
[TBL] [Abstract][Full Text] [Related]
20. Scanning electron microscopy of scales from pityriasis amiantacea.
Batten TL; White MI; Gregory DW
Acta Derm Venereol; 1993 Oct; 73(5):376-7. PubMed ID: 7904406
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
